Asymmetrical manifestation of faciobrachial dystonic seizures in leucine‐rich, glioma‐inactivated 1 antibody encephalitis: A case report
Sign Up to like & getrecommendations! Published in 2020 at "Clinical and Experimental Neuroimmunology"
DOI: 10.1111/cen3.12621
Abstract: Leucine‐rich, glioma‐inactivated (LGI1) antibody encephalitis is a rare autoimmune encephalitis characterized by faciobrachial dystonic seizures (FBDS), temporal lobe epilepsy, prominent short‐term memory deficits and altered mental status. FBDS are very brief, frequent stereotypical dystonic seizures… read more here.
Keywords: leucine rich; dystonic seizures; antibody encephalitis; encephalitis ... See more keywords
Seizure underreporting in LGI1 and CASPR2 antibody encephalitis
Sign Up to like & getrecommendations! Published in 2022 at "Epilepsia"
DOI: 10.1111/epi.17338
Abstract: Patients with anti‐leucine‐rich glioma‐inactivated 1 protein (LGI1) or anti‐contactin‐associated protein 2 (CASPR2) antibody encephalitis typically present with frequent epileptic seizures. The seizures generally respond well to immunosuppressive therapy, and the long‐term seizure outcome seems to… read more here.
Keywords: seizure; caspr2 antibody; antibody encephalitis; lgi1 caspr2 ... See more keywords
Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study
Sign Up to like & getrecommendations! Published in 2018 at "BMC Neurology"
DOI: 10.1186/s12883-018-1099-z
Abstract: BackgroundRecently, most reports of Leucine-rich glioma-inactivated 1 (LGI1) antibody encephalitis are from Europe and the US, while the short term outcome and clinical characteristics of Chinese patients are rarely reported,we study the clinical manifestations, laboratory… read more here.
Keywords: antibody encephalitis; short term; lgi1 antibody;